Domchek SM, Younger J, Finkelstein DM, Seiden MV
Predictors of skeletal complications in patients with metastatic breast carcinoma. Cancer. 2000 Jul 15; 89(2):363-8.
Predictors of skeletal complications in patients with metastatic breast carcinoma.
Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La Monte S, Ojeman RG, Munzenrider JE
International journal of radiation oncology, biology, physics
Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1363-70.
Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy.
Breathnach OS, Kwiatkowski DJ, Finkelstein DM, Godleski J, Sugarbaker DJ, Johnson BE, Mentzer S
The Journal of thoracic and cardiovascular surgery
Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg. 2001 Jan; 121(1):42-7.
Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease.
Laser treatment of macular edema resulting from branch vein occlusion. Semin Ophthalmol. 1994 Mar; 9(1):23-8.
Laser treatment of macular edema resulting from branch vein occlusion.
Combining mortality and longitudinal measures in clinical trials. Stat Med. 1999 Jun 15; 18(11):1341-54.
Combining mortality and longitudinal measures in clinical trials.
Ettinger DS, Finkelstein DM, Ritch PS, Lincoln ST, Blum RH
Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588). Lung Cancer. 2002 Sep; 37(3):311-8.
Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
Amrein PC, Clark JR, Supko JG, Fabian RL, Wang CC, Colevas AD, Posner MR, Deschler DG, Rocco JW, Finkelstein DM, McIntyre JF
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma. Cancer. 2005 Oct 01; 104(7):1418-27.
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma.
A proportional hazards model for interval-censored failure time data. Biometrics. 1986 Dec; 42(4):845-54.
A proportional hazards model for interval-censored failure time data.
Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1994 Jun; 17(3):215-7.
Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study.
Bonomi PD, Finkelstein D, Aisner S, Ettinger D
EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol. 1993 Aug; 16(4):342-5.
EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma.
Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, Dolin R, Cotton D
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 01; 12(1):38-45.
J Acquir Immune Defic Syndr Hum Retrovirol
Patterns of opportunistic infections in patients with HIV infection.
Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L
Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1997 Feb; 130(2):257-65.
Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus.
Cultural diversity and informed consent. J Clin Ethics. 1998; 9(2):173-6.
Cultural diversity and informed consent.
Para MF, Finkelstein D, Becker S, Dohn M, Walawander A, Black JR
Journal of acquired immune deficiency syndromes (1999)
Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268. J Acquir Immune Defic Syndr. 2000 Aug 01; 24(4):337-43.
Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.
Rajicic N, Finkelstein DM, Schoenfeld DA
Survival analysis of longitudinal microarrays. Bioinformatics. 2006 Nov 01; 22(21):2643-9.
Survival analysis of longitudinal microarrays.
Finkelstein DM, Goggins WB, Schoenfeld DA
Analysis of failure time data with dependent interval censoring. Biometrics. 2002 Jun; 58(2):298-304.
Analysis of failure time data with dependent interval censoring.
Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes. Stat Med. 2002 Dec 30; 21(24):3897-911.
Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes.
Finkelstein DM, Wang R, Ficociello LH, Schoenfeld DA
A score test for association of a longitudinal marker and an event with missing data. Biometrics. 2010 Sep; 66(3):726-32.
A score test for association of a longitudinal marker and an event with missing data.
Finkelstein DM, Muzikansky A, Schoenfeld DA
Journal of the National Cancer Institute
Comparing survival of a sample to that of a standard population. J Natl Cancer Inst. 2003 Oct 01; 95(19):1434-9.
Comparing survival of a sample to that of a standard population.
Rizvi I, Celli JP, Evans CL, Abu-Yousif AO, Muzikansky A, Pogue BW, Finkelstein D, Hasan T
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res. 2010 Nov 15; 70(22):9319-28.
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.
Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, Knaul F, Mohar A, Finkelstein DM, Goss PE
Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol. 2012 Aug; 13(8):e335-43.
Breast cancer in Mexico: a growing challenge to health and the health system.
Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD, Hodin RA
Archives of surgery (Chicago, Ill. : 1960)
Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg. 2007 Apr; 142(4):381-6.
Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas.
Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, Griffin CA, Sutphen R, Brzosowicz J, Gruber S, Finkelstein DM, Schildkraut JM
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Res Treat. 2010 Nov; 124(2):441-51.
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted method. J Clin Oncol. 2011 Mar 20; 29(9):1093-5.
Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted method.
Lowery JT, Marcus A, Kinney A, Bowen D, Finkelstein DM, Horick N, Garrett K, Haile R, Sandler R, Ahnen DJ
The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. Contemp Clin Trials. 2012 Mar; 33(2):426-35.
The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families.
Debiasi M, Polanczyk CA, Ziegelmann P, Barrios C, Cao H, Dignam JJ, Goss P, Bychkovsky B, Finkelstein DM, Guindalini RS, Filho P, Albuquerque C, Reinert T, de Azambuja E, Olopade O
Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis. Front Oncol. 2018; 8:156.
Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis.
Johns JA, Gold HK, Leinbach RC, Yasuda T, Gimple LW, Werner W, Finkelstein D, Newell J, Ziskind AA, Collen D
Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator. Circulation. 1988 Sep; 78(3):546-56.
Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator.
Pierie JP, Choudry U, Muzikansky A, Finkelstein DM, Ott MJ
Journal of the American College of Surgeons
Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. J Am Coll Surg. 2003 Jan; 196(1):45-50.
Prognosis and management of extramammary Paget's disease and the association with secondary malignancies.
Kaul S, Finkelstein DM, Homma S, Leavitt M, Okada RD, Boucher CA
Journal of the American College of Cardiology
Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol. 1988 Jul; 12(1):25-34.
Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization.
Ferrone CR, Finkelstein DM, Thayer SP, Muzikansky A, Fernandez-delCastillo C, Warshaw AL
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol. 2006 Jun 20; 24(18):2897-902.
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.
Ettinger DS, Finkelstein DM, Abeloff MD, Chang YC, Smith TJ, Oken MM, Ruckdeschel JC
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer. Invest New Drugs. 1990 May; 8(2):183-5.
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer.
Rajicic N, Cuschieri J, Finkelstein DM, Miller-Graziano CL, Hayden D, Moldawer LL, Moore E, O'Keefe G, Pelik K, Warren HS, Schoenfeld DA
Identification and interpretation of longitudinal gene expression changes in trauma. PLoS One. 2010 Dec 20; 5(12):e14380.
Identification and interpretation of longitudinal gene expression changes in trauma.
Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN
Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med. 1988 Jan 07; 318(1):19-24.
Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome.
Ruckdeschel JC, Finkelstein DM, Mason BA, Creech RH
Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens. J Clin Oncol. 1985 Jan; 3(1):72-9.
Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.
Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, van der Horst C, Koletar SL, Eyster ME, Carey J, Waskin H
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 1995 Mar 16; 332(11):700-5.
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Locke SE, Kowaloff HB, Hoff RG, Safran C, Popovsky MA, Cotton DJ, Finkelstein DM, Page PL, Slack WV
M.D. computing : computers in medical practice
Computer interview for screening blood donors for risk of HIV transmission. MD Comput. 1994 Jan-Feb; 11(1):26-32.
Computer interview for screening blood donors for risk of HIV transmission.
Crippa S, Fernández-Del Castillo C, Salvia R, Finkelstein D, Bassi C, Domínguez I, Muzikansky A, Thayer SP, Falconi M, Mino-Kenudson M, Capelli P, Lauwers GY, Partelli S, Pederzoli P, Warshaw AL
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):213-9.
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.
Nehra D, Oyarvide VM, Mino-Kenudson M, Thayer SP, Ferrone CR, Wargo JA, Muzikansky A, Finkelstein D, Warshaw AL, Castillo CF
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? Pancreatology. 2012 Jul-Aug; 12(4):358-63.
Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter?
Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannom DS, McGovern BA, Kelly E, Vlahakes GJ, Torchiana DF, Ruskin JN
Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation. 1993 Sep; 88(3):1083-92.
Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.
Perrin JM, Greenspan P, Bloom SR, Finkelstein D, Yazdgerdi S, Leventhal JM, Rodewald L, Szilagyi P, Homer CJ
Archives of pediatrics & adolescent medicine
Primary care involvement among hospitalized children. Arch Pediatr Adolesc Med. 1996 May; 150(5):479-86.
Primary care involvement among hospitalized children.
Kuchar DL, Garan H, Venditti FJ, Finkelstein D, Rottman JN, McComb J, McGovern BA, Ruskin JN
Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol. 1989 Jul 01; 64(1):33-6.
Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
Skates SJ, Mai P, Horick NK, Piedmonte M, Drescher CW, Isaacs C, Armstrong DK, Buys SS, Rodriguez GC, Horowitz IR, Berchuck A, Daly MB, Domchek S, Cohn DE, Van Le L, Schorge JO, Newland W, Davidson SA, Barnes M, Brewster W, Azodi M, Nerenstone S, Kauff ND, Fabian CJ, Sluss PM, Nayfield SG, Kasten CH, Finkelstein DM, Greene MH, Lu K
Cancer prevention research (Philadelphia, Pa.)
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Cancer Prev Res (Phila). 2011 Sep; 4(9):1401-8.
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.
Bell DW, Brannigan BW, Matsuo K, Finkelstein DM, Sordella R, Settleman J, Mitsudomi T, Haber DA
Clinical cancer research : an official journal of the American Association for Cancer Research
Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms. Clin Cancer Res. 2008 Jul 01; 14(13):4079-84.
Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms.
Graphing the Win Ratio and its components over time. Stat Med. 2019 01 15; 38(1):53-61.
Graphing the Win Ratio and its components over time.
Morse RE, Nadkarni P, Schoenfeld DA, Finkelstein DM
BMC medical informatics and decision making
Web-browser encryption of personal health information. BMC Med Inform Decis Mak. 2011 Nov 10; 11:70.
Web-browser encryption of personal health information.
Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS
Clinical journal of the American Society of Nephrology : CJASN
Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol. 2007 May; 2(3):461-9.
Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
Gill JB, Ruddy TD, Newell JB, Finkelstein DM, Strauss HW, Boucher CA
Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med. 1987 12 10; 317(24):1485-9.
Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease.
Horick NK, Muzikansky A, Gutierrez HL, Boyd KL, Finkelstein DM
Journal of cancer survivorship : research and practice
Physical symptoms in long-term survivors of rare cancer. J Cancer Surviv. 2018 12; 12(6):835-842.
Physical symptoms in long-term survivors of rare cancer.
Ramchandani R, Finkelstein DM, Schoenfeld DA
Estimation for an accelerated failure time model with intermediate states as auxiliary information. Lifetime Data Anal. 2020 01; 26(1):1-20.
Estimation for an accelerated failure time model with intermediate states as auxiliary information.
Cotton DJ, Powderly WG, Feinberg J, Abrams DI, Chaisson RE, Wheat LJ, Finkelstein DM, Tallman V, Zimmer B, Berzon R
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials Group. Clin Infect Dis. 1993 Jun; 16(6):816-22; discussion 823-4.
Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials Group.
Homer CJ, Szilagyi P, Rodewald L, Bloom SR, Greenspan P, Yazdgerdi S, Leventhal JM, Finkelstein D, Perrin JM
Does quality of care affect rates of hospitalization for childhood asthma? Pediatrics. 1996 Jul; 98(1):18-23.
Does quality of care affect rates of hospitalization for childhood asthma?
A non-parametric maximum likelihood estimator for bivariate interval censored data. Stat Med. 1999 Nov 30; 18(22):3089-100.
A non-parametric maximum likelihood estimator for bivariate interval censored data.
Finkelstein DM, Ettinger DS, Ruckdeschel JC
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol. 1986 May; 4(5):702-9.
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
A proportional hazards model for truncated AIDS data. Biometrics. 1993 Sep; 49(3):731-40.
A proportional hazards model for truncated AIDS data.
Garan H, Kuchar D, Freeman C, Finkelstein D, Ruskin JN
Early assessment of the effect of map-guided transcatheter intracardiac electric shock on sustained ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1988 May 01; 61(13):1018-23.
Early assessment of the effect of map-guided transcatheter intracardiac electric shock on sustained ventricular tachycardia secondary to coronary artery disease.
Schoenfeld DA, Finkelstein DM, Richman DD
Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point. AIDS. 1993 Jul; 7(7):955-8.
Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point.
Analysing survival in the presence of an auxiliary variable. Stat Med. 1994 Sep 15; 13(17):1747-54.
Analysing survival in the presence of an auxiliary variable.
Archives of ophthalmology (Chicago, Ill. : 1960)
Informed consent and medical ethics. Arch Ophthalmol. 1993 Mar; 111(3):324-6.
Green SB, Ellenberg SS, Finkelstein D, Forsythe AB, Freedman LS, Freeman K, Lefkopoulou M, Schoenfeld D, Smith RP
Issues in the design of drug trials for AIDS. Control Clin Trials. 1990 Apr; 11(2):80-7.
Issues in the design of drug trials for AIDS.
Matthews AG, Finkelstein DM, Betensky RA
Multivariate logistic regression for familial aggregation in age at disease onset. Lifetime Data Anal. 2007 Jun; 13(2):191-209.
Multivariate logistic regression for familial aggregation in age at disease onset.
Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM
A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1988 Dec; 11(6):630-3.
A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study.
Weinger K, Jacobson AM, Draelos MT, Finkelstein DM, Simonson DC
Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus. Am J Med. 1995 Jan; 98(1):22-31.
Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus.
Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG
High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 1997 Mar 15; 79(6):1203-10.
High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.
Cariappa A, Sands B, Forcione D, Finkelstein D, Podolsky DK, Pillai S
Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease. Gut. 1998 Aug; 43(2):210-5.
Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease.
Wolfe BE, Metzger ED, Levine JM, Finkelstein DM, Cooper TB, Jimerson DC
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Serotonin function following remission from bulimia nervosa. Neuropsychopharmacology. 2000 Mar; 22(3):257-63.
Serotonin function following remission from bulimia nervosa.
Computer-based interview for screening blood donors for risk of HIV transmission. JAMA. 1992 Sep 09; 268(10):1301-5.
Computer-based interview for screening blood donors for risk of HIV transmission.
Myojin M, Choi NC, Wright CD, Wain JC, Harris N, Hug EB, Mathisen DJ, Lynch T, Carey RW, Grossbard M, Finkelstein DM, Grillo HC
Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):927-33.
Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study.
Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S
The Cancer Genetics Network: recruitment results and pilot studies. Community Genet. 2003; 6(3):171-7.
The Cancer Genetics Network: recruitment results and pilot studies.
Garabedian HD, Gold HK, Yasuda T, Johns JA, Finkelstein DM, Gaivin RJ, Cobbaert C, Leinbach RC, Collen D
Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. J Am Coll Cardiol. 1988 Apr; 11(4):729-34.
Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography.
A semiparametric model for regression analysis of interval-censored failure time data. Biometrics. 1985 Dec; 41(4):933-45.
A semiparametric model for regression analysis of interval-censored failure time data.
Safrin S, Finkelstein DM, Feinberg J, Frame P, Simpson G, Wu A, Cheung T, Soeiro R, Hojczyk P, Black JR
Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group. Ann Intern Med. 1996 May 01; 124(9):792-802.
Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
Finkelstein DM, Horick NK, Ramchandani R, Boyd KL, Rana HQ, Bychkovsky BL
Are rare cancer survivors at elevated risk of subsequent new cancers? BMC Cancer. 2019 Feb 21; 19(1):166.
Are rare cancer survivors at elevated risk of subsequent new cancers?
Communications in statistics. Case studies, data analysis and applications
Informatively clustering longitudinal microarrays using binary or survival outcome data. Commun Stat Case Stud Data Anal Appl. 2018; 4(1):18-27.
Informatively clustering longitudinal microarrays using binary or survival outcome data.
Harvard T.H. Chan School of Public Health
John L. Loeb and Frances Lehman Loeb Professor of Epidemiology
Graham Andrew Colditz, Dr.P.H., M.B.,B.S., M.D.
Schoenfeld DA, Finkelstein DM, Macklin E, Zach N, Ennist DL, Taylor AA, Atassi N
Design and analysis of a clinical trial using previous trials as historical control. Clin Trials. 2019 10; 16(5):531-538.
Design and analysis of a clinical trial using previous trials as historical control.
Coleman R, Finkelstein DM, Barrios C, Martin M, Iwata H, Hegg R, Glaspy J, Periañez AM, Tonkin K, Deleu I, Sohn J, Crown J, Delaloge S, Dai T, Zhou Y, Jandial D, Chan A
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2020 01; 21(1):60-72.
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.
Reyes S, Horick N, Clark J, Murphy J, Blaszkowsky L, Allen J, Ryan DP, Hong T, Wo J, Nipp R, Parikh A, Faris J, Kwak E, Galway A, Knowles M, Oklu R, John IA, Lennerz J, Finkelstein D, Borger D, Zhu A, Goyal L
Annals of oncology : official journal of the European Society for Medical Oncology
Frequency and impact of tumor genotyping in clinical practice of patients with advanced biliary tract cancers (ABTCs). Ann Oncol. 2017 Jun; 28 Suppl 3:iii145-iii146.
Frequency and impact of tumor genotyping in clinical practice of patients with advanced biliary tract cancers (ABTCs).
North CM, Barczak A, Goldstein RH, Healy BC, Finkelstein DM, Ding DD, Kim A, Boucau J, Shaw B, Gilbert RF, Vyas T, Reynolds Z, Siddle KJ, MacInnis BL, Regan J, Flynn JP, Choudhary MC, Vyas JM, Laskowski K, Dighe AS, Lemieux JE, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination. Clin Infect Dis. 2022 04 09; 74(7):1275-1278.
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.
Black JR, Feinberg J, Murphy RL, Fass RJ, Finkelstein D, Akil B, Safrin S, Carey JT, Stansell J, Plouffe JF
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044. Clin Infect Dis. 1994 Jun; 18(6):905-13.
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.
Frenk NE, Spring L, Muzikansky A, Vadvala HV, Gurski JM, Henderson LE, Mino-Kenudson M, Ly A, Bardia A, Finkelstein D, Engelman J, Mueller PR, Juric D, Weissleder R
High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors. JCO Precis Oncol. 2017 Nov; 1:1-9.
High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors.
Schoenfeld DA, Ramchandani R, Finkelstein DM
Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation. Stat Med. 2022 10 30; 41(24):4745-4755.
Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation.
Brem S, Brem H, Folkman J, Finkelstein D, Patz A
Prolonged tumor dormancy by prevention of neovascularization in the vitreous. Cancer Res. 1976 Aug; 36(8):2807-12.
Prolonged tumor dormancy by prevention of neovascularization in the vitreous.
Specht MC, Miller CL, Russell TA, Horick N, Skolny MN, O'Toole JA, Jammallo LS, Niemierko A, Sadek BT, Shenouda MN, Finkelstein DM, Smith BL, Taghian AG
Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat. 2013 Aug; 140(3):485-94.
Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?
Finkelstein D, Lamba V, Assem M, Rengelshausen J, Yasuda K, Strom S, Schuetz E
Xenobiotica; the fate of foreign compounds in biological systems
ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics. Xenobiotica. 2006 Oct-Nov; 36(10-11):989-1012.
ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics.
Welty LJ, Carter RE, Finkelstein DM, Harrell FE, Lindsell CJ, Macaluso M, Mazumdar M, Nietert PJ, Oster RA, Pollock BH, Roberson PK, Ware JH
Academic medicine : journal of the Association of American Medical Colleges
Strategies for developing biostatistics resources in an academic health center. Acad Med. 2013 Apr; 88(4):454-60.
Strategies for developing biostatistics resources in an academic health center.
Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G
Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013 Apr; 14(5):391-436.
Planning cancer control in Latin America and the Caribbean.
Sgroi DC, Carney E, Zarrella E, Steffel L, Binns SN, Finkelstein DM, Szymonifka J, Bhan AK, Shepherd LE, Zhang Y, Schnabel CA, Erlander MG, Ingle JN, Porter P, Muss HB, Pritchard KI, Tu D, Rimm DL, Goss PE
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker. J Natl Cancer Inst. 2013 Jul 17; 105(14):1036-42.
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.
Liedke PE, Finkelstein DM, Szymonifka J, Barrios CH, Chavarri-Guerra Y, Bines J, Vasconcelos C, Simon SD, Goss PE
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):126-33.
Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study.
Hill DA, Horick NK, Isaacs C, Domchek SM, Tomlinson GE, Lowery JT, Kinney AY, Berg JS, Edwards KL, Moorman PG, Plon SE, Strong LC, Ziogas A, Griffin CA, Kasten CH, Finkelstein DM
Long-term risk of medical conditions associated with breast cancer treatment. Breast Cancer Res Treat. 2014 May; 145(1):233-43.
Long-term risk of medical conditions associated with breast cancer treatment.
Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, Lindor NM, Newcomb PA, Sandler RS, Burke C, Hill DA, Ahnen DJ
A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):601-10.
A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network.
A joint test for progression and survival with interval-censored data from a cancer clinical trial. Stat Med. 2014 May 30; 33(12):1981-9.
A joint test for progression and survival with interval-censored data from a cancer clinical trial.
Kawauchi D, Ogg RJ, Liu L, Shih DJH, Finkelstein D, Murphy BL, Rehg JE, Korshunov A, Calabrese C, Zindy F, Phoenix T, Kawaguchi Y, Gronych J, Gilbertson RJ, Lichter P, Gajjar A, Kool M, Northcott PA, Pfister SM, Roussel MF
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells. Oncogene. 2017 09 14; 36(37):5231-5242.
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.
Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE
Breast cancer in China. Lancet Oncol. 2014 Jun; 15(7):e279-89.
Schaid DJ, Spraggs CF, McDonnell SK, Parham LR, Cox CJ, Ejlertsen B, Finkelstein DM, Rappold E, Curran J, Cardon LR, Goss PE
Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury. J Clin Oncol. 2014 Aug 01; 32(22):2296-303.
Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury.
Chavarri-Guerra Y, St Louis J, Liedke PE, Symecko H, Villarreal-Garza C, Mohar A, Finkelstein DM, Goss PE
Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective. BMC Cancer. 2014 Sep 09; 14:658.
Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective.
Chavarri-Guerra Y, Higgins MJ, Szymonifka J, Cigler T, Liedke P, Partridge A, Ligibel J, Come SE, Finkelstein D, Ryan PD, Goss PE
Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy. Br J Cancer. 2014 Nov 25; 111(11):2046-50.
Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.
Ager EI, Kozin SV, Kirkpatrick ND, Seano G, Kodack DP, Askoxylakis V, Huang Y, Goel S, Snuderl M, Muzikansky A, Finkelstein DM, Dransfield DT, Devy L, Boucher Y, Fukumura D, Jain RK
Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy. J Natl Cancer Inst. 2015 Apr; 107(4).
Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
Fischl MA, Finkelstein DM, He W, Powderly WG, Triozzi PL, Steigbigel RT
A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Apr 01; 11(4):379-84.
A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
Boyle FM, Smith IE, O'Shaughnessy J, Ejlertsen B, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Amonkar M, Huang Y, Rappold E, Williams LS, Wang-Silvanto J, Kaneko T, Finkelstein DM, Goss PE
European journal of cancer (Oxford, England : 1990)
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. Eur J Cancer. 2015 Apr; 51(6):685-96.
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.
A model-informed rank test for right-censored data with intermediate states. Stat Med. 2015 Apr 30; 34(9):1454-66.
A model-informed rank test for right-censored data with intermediate states.
Isakoff SJ, Mayer EL, He L, Traina TA, Carey LA, Krag KJ, Rugo HS, Liu MC, Stearns V, Come SE, Timms KM, Hartman AR, Borger DR, Finkelstein DM, Garber JE, Ryan PD, Winer EP, Goss PE, Ellisen LW
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer. J Clin Oncol. 2015 Jun 10; 33(17):1902-9.
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.
Strasser-Weippl K, Ramchandani R, Fan L, Li J, Hurlbert M, Finkelstein D, Shao ZM, Goss PE
Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis. Breast Cancer Res Treat. 2015 Jan; 149(1):255-61.
Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis.
Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. Breast Cancer Res. 2015 Apr 16; 17:56.
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
O'Donnell E, Mahindra A, Yee AJ, Nardi V, Birrer N, Horick N, Borger D, Finkelstein D, Iafrate JA, Raje N
Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma. EBioMedicine. 2015 Jan; 2(1):71-3.
Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma.
Current concepts in the management of central retinal vein occlusion. Curr Opin Ophthalmol. 1997 Jun; 8(3):50-4.
Current concepts in the management of central retinal vein occlusion.
Cotton DJ, Finkelstein DM, He W, Feinberg J
Journal of acquired immune deficiency syndromes
Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1988). 1993 Dec; 6(12):1322-8.
Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group.
Donato R, Cheema S, Finkelstein D, Bartlett P, Morrison W
Annals of the Academy of Medicine, Singapore
Role of leukaemia inhibitory factor (LIF) in rat peripheral nerve regeneration. Ann Acad Med Singap. 1995 Jul; 24(4 Suppl):94-100.
Role of leukaemia inhibitory factor (LIF) in rat peripheral nerve regeneration.
Dunn JP, Noorily SW, Petri M, Finkelstein D, Rosenbaum JT, Jabs DA
Antiphospholipid antibodies and retinal vascular disease. Lupus. 1996 Aug; 5(4):313-22.
Antiphospholipid antibodies and retinal vascular disease.
Outcome-Driven Cluster Analysis with Application to Microarray Data. PLoS One. 2015; 10(11):e0141874.
Outcome-Driven Cluster Analysis with Application to Microarray Data.
Patel SG, Ahnen DJ, Kinney AY, Horick N, Finkelstein DM, Hill DA, Lindor NM, MaCrae F, Lowery JT
The American journal of gastroenterology
Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project. Am J Gastroenterol. 2016 Feb; 111(2):285-93.
Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project.
Buranasiri S, Baum S, Nusbaum M, Finkelstein D
Periarteritis of the middle colic artery. Arteriographic, surgical and pathological correlation. Am J Gastroenterol. 1973 Jan; 59(1):73-6.
Periarteritis of the middle colic artery. Arteriographic, surgical and pathological correlation.
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. Eur J Cancer. 2016 Mar; 56:85-92.
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.
Mazumdar M, Messinger S, Finkelstein DM, Goldberg JD, Lindsell CJ, Morton SC, Pollock BH, Rahbar MH, Welty LJ, Parker RA
Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework. Acad Med. 2015 Oct; 90(10):1302-8.
Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework.
Assessing survival benefit when treatment delays disease progression. Clin Trials. 2016 06; 13(3):352-7.
Assessing survival benefit when treatment delays disease progression.
GVL without GVHD across HLA barriers: Translational Studies
COORDINATING CENTER FOR THE CANCER GENETICS NETWORK
Methods for Statistical Analysis of Cancer Genetic Network Studies
CARCINOGENICITY EXPERIMENTS FOR ENVIRONMENTAL HEALTH
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
STATISTICAL METHODS FOR RESEARCH IN CANCER AND AIDS
STATISTICAL METHODS FOR FAILURE TIME DATE IN AIDS
Analysis of Longitudinal High Dimensional Data for Burn and Trauma Studies
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
Analysis of Risks and Outcomes for Rare Cancers
Ramchandani R, Schoenfeld DA, Finkelstein DM
Global rank tests for multiple, possibly censored, outcomes. Biometrics. 2016 09; 72(3):926-35.
Global rank tests for multiple, possibly censored, outcomes.
Dwojak SM, Finkelstein DM, Emerick KS, Lee JH, Petereit DG, Deschler DG
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Poor Survival for American Indians with Head and Neck Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2014 08; 151(2):265-71.
Poor Survival for American Indians with Head and Neck Squamous Cell Carcinoma.
Horick NK, Manful A, Lowery J, Domchek S, Moorman P, Griffin C, Visvanathan K, Isaacs C, Kinney AY, Finkelstein DM
Physical and psychological health in rare cancer survivors. J Cancer Surviv. 2017 02; 11(1):158-165.
Physical and psychological health in rare cancer survivors.
Chavarri-Guerra Y, St Louis J, Bukowski A, Soto-Perez-de-Celis E, Liedke PER, Symecko H, Moy B, Higgins M, Finkelstein DM, Goss PE
Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011. Breast. 2017 Feb; 31:197-201.
Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011.
The Annals of otology, rhinology, and laryngology
Red blood cell scan in cavernous hemangioma of the larynx. Ann Otol Rhinol Laryngol. 1989 Sep; 98(9):707-12.
Red blood cell scan in cavernous hemangioma of the larynx.
McShane DP, Hyde ML, Finkelstein DM, Alberti PW
Clinical otolaryngology and allied sciences
Unilateral otosclerosis and noise-induced occupational hearing loss. Clin Otolaryngol Allied Sci. 1991 Feb; 16(1):70-5.
Unilateral otosclerosis and noise-induced occupational hearing loss.
Sgroi D, Carney E, Richardson E, Steffel L, Binns SN, Finkelstein DM, Shepherd LE, Kesty NC, Schnabel C, Erlander MG, Ingle JN, Porter P, Paik S, Muss HB, Pritchard KI, Tu D, Goss PE
Prediction of late recurrences by breast cancer index in the NCIC CTG MA.17 cohort. J Clin Oncol. 2011 Sep 20; 29(27_suppl):2.
Prediction of late recurrences by breast cancer index in the NCIC CTG MA.17 cohort.
Carp SA, Wanyo C, Specht MC, Schapira L, Moy B, Finkelstein DM, Boas D, Isakoff SJ
Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer. J Clin Oncol. 2011 Sep 20; 29(27_suppl):60.
Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer.
Goss PE, Barrios CH, Chan A, Chia SK, Delaloge S, Ejlertsen B, Ingle JN, Moy B, Iwata H, Holmes FA, Mansi J, Von Minckwitz G, Han L, Thiele A, Agrapart V, Freyman A, Truscello J, Berkenblit A, Finkelstein D
A phase III trial of adjuvant neratinib (NER) after trastuzumab (TRAS) in women with early-stage HER2+ breast cancer (BC). J Clin Oncol. 2011 May 20; 29(15_suppl):TPS137.
A phase III trial of adjuvant neratinib (NER) after trastuzumab (TRAS) in women with early-stage HER2+ breast cancer (BC).
Cigler T, Higgins MJ, Szymonifka J, Partridge AH, Ligibel JA, Finkelstein D, Come SE, Ryan PD, Goss PE
A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy. J Clin Oncol. 2011 May 20; 29(15_suppl):559.
A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy.
Goss PE, Barrios CH, Bell R, Finkelstein D, Iwata H, Martin M, Braun AH, Dansey RD, Coleman RE
A randomized, double-blind, placebo-controlled multicenter phase III study comparing denosumab with placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE). J Clin Oncol. 2011 May 20; 29(15_suppl):TPS152.
A randomized, double-blind, placebo-controlled multicenter phase III study comparing denosumab with placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE).
Isakoff SJ, Goss PE, Mayer EL, Traina TA, Carey LA, Krag K, Rugo HS, Liu MC, Stearns V, Come SE, Borger DR, Quadrino CA, Finkelstein D, Garber JE, Ryan PD, Winer EP, Ellisen LW
TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response. J Clin Oncol. 2011 May 20; 29(15_suppl):1025.
TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response.
Carp SA, Wanyo C, Specht M, Schapira L, Moy B, Finkelstein D, Boas D, Isakoff SJ
Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):10607.
Skates SJ, Greene MH, Buys SS, Mai PL, Brown P, Piedmonte M, Rodriguez G, Schorge JO, Sherman M, Daly MB, Rutherford T, Brewster WR, O'Malley DM, Partridge E, Boggess J, Drescher CW, Isaacs C, Berchuck A, Domchek S, Davidson SA, Edwards R, Elg SA, Wakeley K, Phillips KA, Armstrong D, Horowitz I, Fabian CJ, Walker J, Sluss PM, Welch W, Minasian L, Horick NK, Kasten CH, Nayfield S, Alberts D, Finkelstein DM, Lu KH
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials. Clin Cancer Res. 2017 Jul 15; 23(14):3628-3637.
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
Choroidal rupture. Clinicopathologic correlation of an unusual case. Retina. 1996; 16(1):57-63.
Choroidal rupture. Clinicopathologic correlation of an unusual case.
Shebani KO, Souba WW, Finkelstein DM, Stark PC, Elgadi KM, Tanabe KK, Ott MJ
Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg. 1999 Jun; 229(6):815-21; discussion 822-3.
Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.
Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG
Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol. 2000 Sep; 136(9):1118-22.
Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.
Dubovy SR, Hairston RJ, Schatz H, Schachat AP, Bressler NM, Finkelstein D, Green WR
Adult-onset foveomacular pigment epithelial dystrophy: clinicopathologic correlation of three cases. Retina. 2000; 20(6):638-49.
Adult-onset foveomacular pigment epithelial dystrophy: clinicopathologic correlation of three cases.
Finkelstein D, Wu AW, Holtzman NA, Smith MK
When a physician harms a patient by a medical error: ethical, legal, and risk-management considerations. J Clin Ethics. 1997; 8(4):330-5.
When a physician harms a patient by a medical error: ethical, legal, and risk-management considerations.
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000 Sep; 56(3):779-88.
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.
Goggins WB, Finkelstein DM, Zaslavsky AM
Applying the Cox proportional hazards model when the change time of a binary time-varying covariate is interval censored. Biometrics. 1999 Jun; 55(2):445-51.
Applying the Cox proportional hazards model when the change time of a binary time-varying covariate is interval censored.
Finkelstein DM, Schoenfeld DA, Stamenovic E
Analysis of multiple failure time data from an AIDS clinical trial. Stat Med. 1997 Apr 30; 16(8):951-61.
Analysis of multiple failure time data from an AIDS clinical trial.
Ferrone CR, Thayer SP, Finkelstein DM, Muzikansky A, Mino-Kenudson M, Lauwers G, Warshaw AL
A decrease in preoperative to postoperative CA19-9 level is a significant predictor of survival in patients with pancreatic adenocarcinoma. J Clin Oncol. 2005 Jun; 23(16_suppl):4034.
A decrease in preoperative to postoperative CA19-9 level is a significant predictor of survival in patients with pancreatic adenocarcinoma.
Santoni R, Liebsch N, Finkelstein DM, Hug E, Hanssens P, Goitein M, Smith AR, O'Farrell D, Efird JT, Fullerton B, Munzenrider JE
Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys. 1998 Apr 01; 41(1):59-68.
Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull.
Herrlinger U, Kramm CM, Johnston KM, Louis DN, Finkelstein D, Reznikoff G, Dranoff G, Breakefield XO, Yu JS
Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Cancer Gene Ther. 1997 Nov-Dec; 4(6):345-52.
Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol. 1998 Jan; 116(1):43-52.
Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion.
Hodi FS, Soiffer RJ, Clark J, Finkelstein DM, Haluska FG
Phase II study of paclitaxel and carboplatin for malignant melanoma. Am J Clin Oncol. 2002 Jun; 25(3):283-6.
Phase II study of paclitaxel and carboplatin for malignant melanoma.
Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS
Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003 Jun 05; 348(23):2285-93.
Regression of microalbuminuria in type 1 diabetes.
Jimerson DC, Wolfe BE, Metzger ED, Finkelstein DM, Cooper TB, Levine JM
Decreased serotonin function in bulimia nervosa. Arch Gen Psychiatry. 1997 Jun; 54(6):529-34.
Decreased serotonin function in bulimia nervosa.
Colby C, McAfee SL, Finkelstein DM, Spitzer TR
Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1998 May; 21(10):1005-10.
Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation.
Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T
A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999 Oct; 24(8):897-902.
A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Debus J, Hug EB, Liebsch NJ, O'Farrel D, Finkelstein D, Efird J, Munzenrider JE
Frontiers of radiation therapy and oncology
Dose-volume tolerance of the brainstem after high-dose radiotherapy. Front Radiat Ther Oncol. 1999; 33:305-14.
Dose-volume tolerance of the brainstem after high-dose radiotherapy.
A proportional hazards model for multivariate interval-censored failure time data. Biometrics. 2000 Sep; 56(3):940-3.
A proportional hazards model for multivariate interval-censored failure time data.
Rosenbaum MS, Wilber DJ, Finkelstein D, Ruskin JN, Garan H
Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy. J Am Coll Cardiol. 1991 Jan; 17(1):133-8.
Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy.
Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol. 1992 Oct; 110(10):1427-34.
Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion.
Kim L, Hochberg FH, Thornton AF, Harsh GR, Patel H, Finkelstein D, Louis DN
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas. J Neurosurg. 1996 Oct; 85(4):602-7.
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas.
Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer. 2001 Feb 15; 91(4):874-80.
Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
Testing for dependence between failure time and visit compliance with interval-censored data. Biometrics. 2002 Mar; 58(1):58-63.
Testing for dependence between failure time and visit compliance with interval-censored data.
Garabedian HD, Gold HK, Leinbach RC, Svizzero TA, Finkelstein DM, Guerrero JL, Collen D
Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: potentiation by aspirin and reversal with aprotinin. J Am Coll Cardiol. 1991 Apr; 17(5):1213-22.
Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: potentiation by aspirin and reversal with aprotinin.
Aisner SC, Finkelstein DM, Ettinger DS, Abeloff MD, Ruckdeschel JC, Eggleston JC
The clinical significance of variant-morphology small-cell carcinoma of the lung. J Clin Oncol. 1990 Mar; 8(3):402-8.
The clinical significance of variant-morphology small-cell carcinoma of the lung.
Ettinger DS, Finkelstein DM, Abeloff MD, Skeel RT, Stott PB, Frontiera MS, Bonomi PD
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study. J Natl Cancer Inst. 1992 Jul 15; 84(14):1077-84.
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
Chaudhuri S, Cariappa A, Tang M, Bell D, Haber DA, Isselbacher KJ, Finkelstein D, Forcione D, Pillai S
Proceedings of the National Academy of Sciences of the United States of America
Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc Natl Acad Sci U S A. 2000 Oct 10; 97(21):11451-4.
Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.
Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment. Biometrics. 1991 Jun; 47(2):669-80.
Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment.
Ikeda K, Ichikawa T, Wakimoto H, Silver JS, Deisboeck TS, Finkelstein D, Harsh GR, Louis DN, Bartus RT, Hochberg FH, Chiocca EA
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med. 1999 Aug; 5(8):881-7.
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses.
Shannon KM, Lubratovich ML, Finkelstein DM, Smith BL, Powell SN, Seiden MV
Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center. Cancer. 2002 Jan 15; 94(2):305-13.
Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center.
Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998 Oct 07; 90(19):1473-9.
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
An extension of Kendall's coefficient of concordance to bivariate interval censored data. Stat Med. 1999 Nov 30; 18(22):3101-9.
An extension of Kendall's coefficient of concordance to bivariate interval censored data.
Harsh GR, Deisboeck TS, Louis DN, Hilton J, Colvin M, Silver JS, Qureshi NH, Kracher J, Finkelstein D, Chiocca EA, Hochberg FH
Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. J Neurosurg. 2000 May; 92(5):804-11.
Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study.
Ettinger DS, Finkelstein DM, Donehower RC, Chang AY, Green M, Blum R, Hahn RG, Ruckdeschel JC
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study. Med Pediatr Oncol. 1989; 17(3):197-201.
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study.
Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW
Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Cancer Res. 2010 Apr 01; 16(7):2138-46.
Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Kinney HC, Brody BA, Finkelstein DM, Vawter GF, Mandell F, Gilles FH
Journal of neuropathology and experimental neurology
Delayed central nervous system myelination in the sudden infant death syndrome. J Neuropathol Exp Neurol. 1991 Jan; 50(1):29-48.
Delayed central nervous system myelination in the sudden infant death syndrome.
Tyminski E, Leroy S, Terada K, Finkelstein DM, Hyatt JL, Danks MK, Potter PM, Saeki Y, Chiocca EA
Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan. Cancer Res. 2005 Aug 01; 65(15):6850-7.
Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan.
Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock A, Isselbacher KJ, Haber DA
Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med. 1997 May 15; 336(20):1416-21.
Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys. 1997 Dec 01; 39(5):967-75.
Brainstem tolerance to conformal radiotherapy of skull base tumors.
Byar DP, Schoenfeld DA, Green SB, Amato DA, Davis R, De Gruttola V, Finkelstein DM, Gatsonis C, Gelber RD, Lagakos S
Design considerations for AIDS trials. N Engl J Med. 1990 Nov 08; 323(19):1343-8.
Alm El-Din MA, Hughes KS, Finkelstein DM, Betts KA, Yock TI, Tarbell NJ, Aisenberg AC, Taghian AG
Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):69-74.
Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter.
Ettinger DS, Finkelstein DM, Abeloff MD, Ruckdeschel JC, Aisner SC, Eggleston JC
A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol. 1990 Feb; 8(2):230-40.
A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.
Johns JA, Leavitt MB, Newell JB, Yasuda T, Leinbach RC, Gold HK, Finkelstein D, Dinsmore RE
Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging. J Am Coll Cardiol. 1990 Jan; 15(1):143-9.
Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging.
Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS
Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol. 2005 Mar 01; 23(7):1507-13.
Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.
Parmigiani G, Chen S, Iversen ES, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM
Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med. 2007 Oct 02; 147(7):441-50.
Validity of models for predicting BRCA1 and BRCA2 mutations.
Laser therapy for central retinal vein obstruction. Curr Opin Ophthalmol. 1996 Jun; 7(3):80-3.
Laser therapy for central retinal vein obstruction.
Second malignancies in Hodgkin's disease. J Clin Oncol. 2000 May; 18(10):2186-7.
Second malignancies in Hodgkin's disease.
DiRienzo AG, van Der Horst C, Finkelstein DM, Frame P, Bozzette SA, Tashima KT
Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. AIDS Res Hum Retroviruses. 2002 Jan 20; 18(2):89-94.
Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.
Goss PE, Smith IE, O'Shaughnessy J, Ejlertsen B, Kaufmann M, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Chavarri-Guerra Y, Aktan G, Rappold E, Williams LS, Finkelstein DM
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial. Lancet Oncol. 2013 Jan; 14(1):88-96.
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.
Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA. 2008 Jan 02; 299(1):53-60.
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
Analysis of familial aggregation studies with complex ascertainment schemes. Stat Med. 2008 Oct 30; 27(24):5076-92.
Analysis of familial aggregation studies with complex ascertainment schemes.
Gimple LW, Gold HK, Leinbach RC, Coller BS, Werner W, Yasuda T, Johns JA, Ziskind AA, Finkelstein D, Collen D
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator. Circulation. 1989 Sep; 80(3):581-8.
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Abeloff MD, Finkelstein DM, Chang AY, Camacho FJ, Creech RH, Ettinger DS
Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study. Cancer Treat Rep. 1985 Apr; 69(4):451-2.
Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.
Ettinger DS, Finkelstein DM, Harper GR, Ruckdeschel JC, Chang AY, Camacho FJ, Marsh JC, Silber R, Wolter JM
Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1985 Sep; 69(9):1033-4.
Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.
Schoenfeld DA, Rajicic N, Ficociello LH, Finkelstein DM
A test for the relationship between a time-varying marker and both recovery and progression with missing data. Stat Med. 2011 Mar 30; 30(7):718-24.
A test for the relationship between a time-varying marker and both recovery and progression with missing data.
Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, O'Farrell D, Lyons S, Munzenrider J
Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys. 1999 Sep 01; 45(2):351-8.
Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma.
Ryan DP, Lynch TJ, Grossbard ML, Seiden MV, Fuchs CS, Grenon N, Baccala P, Berg D, Finkelstein D, Mayer RJ, Clark JW
A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors. Cancer. 2000 Jan 01; 88(1):180-5.
A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors.
Applied immunohistochemistry & molecular morphology : AIMM
A reliable method of demonstrating HER-2/neu, estrogen receptors, and progesterone receptors on routinely processed cytologic material. Appl Immunohistochem Mol Morphol. 2001 Dec; 9(4):352-7.
A reliable method of demonstrating HER-2/neu, estrogen receptors, and progesterone receptors on routinely processed cytologic material.
Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G
Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006 Feb 20; 24(6):863-71.
Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Analysis of multiple tumor data from a rodent carcinogenicity experiment. Biometrics. 1989 Mar; 45(1):219-30.
Analysis of multiple tumor data from a rodent carcinogenicity experiment.
Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE
Breast cancer in Brazil: present status and future goals. Lancet Oncol. 2012 Mar; 13(3):e95-e102.
Breast cancer in Brazil: present status and future goals.
Kelly PA, Cannom DS, Garan H, Finkelstein D, McComb JM, Mirabal GS, Ilvento JP, Ruskin JN
Predictors of automatic implantable cardioverter defibrillator discharge for life-threatening ventricular arrhythmias. Am J Cardiol. 1988 Jul 01; 62(1):83-7.
Predictors of automatic implantable cardioverter defibrillator discharge for life-threatening ventricular arrhythmias.
FitzGerald MG, Harkin DP, Silva-Arrieta S, MacDonald DJ, Lucchina LC, Unsal H, O'Neill E, Koh J, Finkelstein DM, Isselbacher KJ, Sober AJ, Haber DA
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci U S A. 1996 Aug 06; 93(16):8541-5.
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
Ott MJ, Tanabe KK, Gadd MA, Stark P, Smith BL, Finkelstein DM, Souba WW
Multimodality management of Merkel cell carcinoma. Arch Surg. 1999 Apr; 134(4):388-92; discussion 392-3.
Multimodality management of Merkel cell carcinoma.
Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med. 1992 Dec 24; 327(26):1842-8.
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
Holroyd S, Rabins PV, Finkelstein D, Lavrisha M
The Journal of nervous and mental disease
Visual hallucinations in patients from an ophthalmology clinic and medical clinic population. J Nerv Ment Dis. 1994 May; 182(5):273-6.
Visual hallucinations in patients from an ophthalmology clinic and medical clinic population.
Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, Loeffler JS, Leibsch NJ, Klibanski A, Munzenrider JE
Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001 Mar 15; 49(4):1079-92.
Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis.
Ancukiewicz M, Finkelstein DM, Schoenfeld DA
Modelling the relationship between continuous covariates and clinical events using isotonic regression. Stat Med. 2003 Oct 30; 22(20):3151-9.
Modelling the relationship between continuous covariates and clinical events using isotonic regression.
Regression analysis of failure time data with informative interval censoring. Stat Med. 2007 May 30; 26(12):2533-46.
Regression analysis of failure time data with informative interval censoring.
Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS
Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol. 2002 Feb 15; 20(4):1063-8.
Quantitatively determined survivin expression levels are of prognostic value in human gliomas.
Bayesian design using adult data to augment pediatric trials. Clin Trials. 2009 Aug; 6(4):297-304.
Bayesian design using adult data to augment pediatric trials.
Chakravatri A, Zehr EM, Zietman AL, Shipley WU, Goggins WB, Finkelstein DM, Young RH, Chang EL, Wu CL
Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study. Urology. 2000 May; 55(5):635-8.
Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study.
Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 1995 Mar 16; 332(11):693-9.
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Bonomi PD, Finkelstein DM, Ruckdeschel JC, Blum RH, Green MD, Mason B, Hahn R, Tormey DC, Harris J, Comis R
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol. 1989 Nov; 7(11):1602-13.
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol. 1993 Mar; 11(3):561-9.
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM
Analysis of co-aggregation of cancer based on registry data. Community Genet. 2006; 9(2):87-92.
Analysis of co-aggregation of cancer based on registry data.
Neklason DW, Kerber RA, Nilson DB, Anton-Culver H, Schwartz AG, Griffin CA, Lowery JT, Schildkraut JM, Evans JP, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Finkelstein DM, Nadkarni PM, Kasten CH, Mineau GP, Burt RW
Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res. 2008 Nov 01; 68(21):8993-7.
Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.
Draelos MT, Jacobson AM, Weinger K, Widom B, Ryan CM, Finkelstein DM, Simonson DC
Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med. 1995 Feb; 98(2):135-44.
Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia.
Matissek KJ, Onozato ML, Sun S, Zheng Z, Schultz A, Lee J, Patel K, Jerevall PL, Saladi SV, Macleay A, Tavallai M, Badovinac-Crnjevic T, Barrios C, Bese N, Chan A, Chavarri-Guerra Y, Debiasi M, Demirdögen E, Egeli Ü, Gökgöz S, Gomez H, Liedke P, Tasdelen I, Tolunay S, Werutsky G, St Louis J, Horick N, Finkelstein DM, Le LP, Bardia A, Goss PE, Sgroi DC, Iafrate AJ, Ellisen LW
Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer. Cancer Discov. 2018 03; 8(3):336-353.
Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.
Mruzek DW, McAleavey S, Loring WA, Butter E, Smith T, McDonnell E, Levato L, Aponte C, Travis RP, Aiello RE, Taylor CM, Wilkins JW, Corbett-Dick P, Finkelstein DM, York AM, Zanibbi K
Autism : the international journal of research and practice
A pilot investigation of an iOS-based app for toilet training children with autism spectrum disorder. Autism. 2019 02; 23(2):359-370.
A pilot investigation of an iOS-based app for toilet training children with autism spectrum disorder.
Analysis of the relationship between longitudinal gene expressions and ordered categorical event data. Stat Med. 2009 Sep 30; 28(22):2817-32.
Analysis of the relationship between longitudinal gene expressions and ordered categorical event data.
Kerber RA, Amos CI, Yeap BY, Finkelstein DM, Thomas DC
Design considerations in a sib-pair study of linkage for susceptibility loci in cancer. BMC Med Genet. 2008 Jul 10; 9:64.
Design considerations in a sib-pair study of linkage for susceptibility loci in cancer.
Souglakos J, Philips J, Wang R, Marwah S, Silver M, Tzardi M, Silver J, Ogino S, Hooshmand S, Kwak E, Freed E, Meyerhardt JA, Saridaki Z, Georgoulias V, Finkelstein D, Fuchs CS, Kulke MH, Shivdasani RA
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer. 2009 Aug 04; 101(3):465-72.
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.
Ruckdeschel JC, Finkelstein DM, Ettinger DS, Creech RH, Mason BA, Joss RA, Vogl S
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. J Clin Oncol. 1986 Jan; 4(1):14-22.
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Peteet JR, Murray-Ross D, Medeiros C, Walsh-Burke K, Rieker P, Finkelstein D
Job stress and satisfaction among the staff members at a cancer center. Cancer. 1989 Aug 15; 64(4):975-82.
Job stress and satisfaction among the staff members at a cancer center.
Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C, Griffin CA, Moorman PG, Edwards KL, Hill DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE
Clinically relevant changes in family history of cancer over time. JAMA. 2011 Jul 13; 306(2):172-8.
Clinically relevant changes in family history of cancer over time.
Ettinger DS, Finkelstein DM, Sarma RP, Johnson DH
Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol. 1995 Jun; 13(6):1430-5.
Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.
FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996 Jan 18; 334(3):143-9.
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.
FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA
Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet. 1997 Mar; 15(3):307-10.
Heterozygous ATM mutations do not contribute to early onset of breast cancer.
Herrlinger U, Kramm CM, Aboody-Guterman KS, Silver JS, Ikeda K, Johnston KM, Pechan PA, Barth RF, Finkelstein D, Chiocca EA, Louis DN, Breakefield XO
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector. Gene Ther. 1998 Jun; 5(6):809-19.
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector.
Current concepts in the management of central retinal vein occlusion. Curr Opin Ophthalmol. 1998 Jun; 9(3):47-50.
Duska LR, Penson R, Supko JG, Finkelstein DM, Makastorsis T, Gallagher J, Borden K, Goodman A, Fuller AF, Nikrui N, Seiden MV
A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer. Clin Cancer Res. 1999 Jun; 5(6):1299-305.
A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.
Goggins WB, Finkelstein DM, Schoenfeld DA, Zaslavsky AM
A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model. Biometrics. 1998 Dec; 54(4):1498-507.
A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model.
Applying the Cox proportional hazards model for analysis of latency data with interval censoring. Stat Med. 1999 Oct 30; 18(20):2737-47.
Applying the Cox proportional hazards model for analysis of latency data with interval censoring.
Fine-needle aspiration cytology of the breast: Invasive vs. in situ carcinoma. Diagn Cytopathol. 2001 Jul; 25(1):73-7.
Fine-needle aspiration cytology of the breast: Invasive vs. in situ carcinoma.